BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33790077)

  • 21. Antagonizing effects of YM-14673, a new TRH derivative, on behavioral and electroencephalographic changes in reserpinized animals.
    Yamamoto M; Shimizu M; Iwai A
    Psychopharmacology (Berl); 1988; 95(2):162-6. PubMed ID: 3137591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
    Bhargava HN; Matwyshyn GA
    Psychopharmacology (Berl); 1985; 87(2):141-6. PubMed ID: 2996045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent effects of oral thyrotropin-releasing hormone in hyperthyroid female rats.
    Iglesias R; Llobera M; Montoya E
    Horm Metab Res; 1986 Jul; 18(7):454-6. PubMed ID: 3091472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipophilic peptides: synthesis of lauroyl thyrotropin-releasing hormone and its biological activity.
    Muranishi S; Sakai A; Yamada K; Murakami M; Takada K; Kiso Y
    Pharm Res; 1991 May; 8(5):649-52. PubMed ID: 1866381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.
    Boghosian JD; Luethy A; Cotten JF
    J Pharmacol Exp Ther; 2018 Jul; 366(1):105-112. PubMed ID: 29674333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism by thyrotropin-releasing hormone of brain temperature in response to pentobarbital in the rat: possible involvement of cholinergic mechanism.
    Yamaguchi M; Mori M; Ishikawa K; Suzuki M
    Proc Soc Exp Biol Med; 1986 Dec; 183(3):368-71. PubMed ID: 3099303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptides and thermoregulation: the interactions of bombesin, neurotensin, TRH, somatostatin, naloxone and prostaglandins.
    Morley JE; Levine AS; Oken MM; Grace M; Kneip J
    Peptides; 1982; 3(1):1-6. PubMed ID: 6123111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogs containing a 1-substituted 2-oxoimidazolidine moiety.
    Maeda H; Suzuki M; Sugano H; Yamamura M; Ishida R
    Int J Pept Protein Res; 1989 Jun; 33(6):403-11. PubMed ID: 2506142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
    J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats.
    Kinoshita K; Nagao T; Ono H
    Neuropharmacology; 1994 Oct; 33(10):1183-8. PubMed ID: 7862253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA; Plotnikoff NP
    J Pharmacol Exp Ther; 1975 Apr; 193(1):11-22. PubMed ID: 805836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration.
    Bhargava HN
    Psychopharmacology (Berl); 1980; 68(2):185-9. PubMed ID: 6776564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.
    Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y
    Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH).
    Cott JM; Breese GR; Cooper BR; Barlow S; Prange AJ
    J Pharmacol Exp Ther; 1976 Mar; 196(3):594-604. PubMed ID: 177753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2.
    Kaur N; Lu X; Gershengorn MC; Jain R
    J Med Chem; 2005 Sep; 48(19):6162-5. PubMed ID: 16162016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of thyrotropin releasing hormone on pentobarbital tolerance.
    Bhargava HN
    Eur J Pharmacol; 1981 Jun; 72(1):63-8. PubMed ID: 6790297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.